Tagged Content

Tags > Medication Updates
Year: Medication:  Abilify (aripiprazole) Addyi Antipsychotics Aripiprazole Aristada Belsomra Brintellix Probuphine Clozapine Cymbalta Daytrana Diazepam Effexor Farxiga Geodon Hysingla ER Lunesta Methylphenidate Naloxone/Evzio Naltrexone Olanzapine Olanzapine/Zyprexa Opioids Rexulti Tanzeum Targiniq ER Tramadol Treatment for Alcohol Use Disorder Vraylar Vynase Ziprasidone Zolpidem Zyprexa General Resources:   DEA Pharmacists' Manual FDA Medication Updates NIMH Mental Health Medications Guide         2016 FDA approves first buprenorphine implant Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence, has been approved as a six-month implant. FDA adds new warning to all olanzapine-containing products The new warning describes the rare but severe condition known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), a skin reaction. FDA warns about impulse-control problems associated with aripiprazole (Abilify, Abilify Maintena, Aristada) FDA reports that compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of aripiprazole, an antipsychotic.



View all tags
View RSS XML
The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

APNA Elections: Make Your Voice Heard!
Elections are now open for the APNA Board of Directors and 2017 Nominating Committee.  |  View

Just Announced! Save 10% on Professional Liability Insurance with CPI
Save 10% on your Risk Management Premium through NSO and HPSO when you attend at least 6 contact hours at the 14th Annual Clinical Psychopharmacology Institute.  |  View

Annual Conference Sessions Now Available Online
Podcast recordings of 63 sessions presented at the APNA 29th Annual Conference are now available online for CE. |  View

March 2016 Members' Corner Now Available
Featuring a message from APNA President Mary Ann Nihart, CPI information, tips for certification exam preparation, and more. |  View

APNA Joins White House Effort to Address Opioid Misuse and Overdose Epidemic in Communities across Nation
The effort seeks to train health care providers, improve access to treatment, and raise awareness of the risks of prescription drug misuse.  |  View